GANX is Gain Therapeutics, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $1.81. Market cap: $79M. Capital Quality Rank: 0/100 — Systemic risk.
Stock snapshot
| Price | $1.81 |
| Market cap | $79M |
| Sector | Healthcare |
| Exchange | NGM |
| Pays dividend | No |
Capital Quality & fundamentals
DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.
| Capital Quality Rank (1-100) | 0 / 100 · Systemic risk |
| Shareholder buyback yield | -30.00% |
| Altman Z-score zone | Safe |
About GANX
Gain Therapeutics Inc is a clinical-stage biotechnology company developing novel small-molecule therapeutics to treat diseases across several therapeutic areas, including central nervous system (CNS) disorders, lysosomal storage disorders (LSDs), metabolic disorders, and other diseases that can be targeted through protein degradation, such as oncology. The Company's clinical stage product candidate, GT-02287, is being developed for the treatment of Parkinson's disease with and without GBA1 mutations. The Company generated an extensive preclinical data package providing evidence of the mechanism of action.
Related non-dividend companies
Other non-dividend stocks investors research alongside GANX. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is GANX's current stock price?
GANX (Gain Therapeutics, Inc.) is currently trading at $1.81.
Does GANX pay a dividend?
GANX (Gain Therapeutics, Inc.) does not currently pay a regular dividend.
What is GANX's Capital Quality Rank?
GANX has a Capital Quality Rank of 0/100 — Systemic risk. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.
Track GANX in DiviDrip
Add GANX to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search GANX and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-04. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.